JUN 20, 2020 10:31 AM PDT

Prolonged Cannabis Use May Prevent Migraines

WRITTEN BY: Annie Lennon

Between 1% and 2% of the world's population suffers from chronic migraines. Researchers from Israel have now found that using medical cannabis for a prolonged period may reduce the number of migraines a person experiences, as well as their intensity. 

For the study, the researchers examined 145 people aged 34-54 with a history of frequent migraines. They had each been using medical cannabis for a median of three years. While 97 of them were women, 48 were men. The researchers collected information from the participants via a self-reported questionnaire as well as information on the characteristics of the medical marijuana they used. 

In the end, they found that 89 of the participants, or 61% of the group, reported a 50% or more reduction in monthly migraines after using medical cannabis. A smaller subgroup of the participants also reported lower current migraine disability and less intense migraine attacks since taking the substance. "These findings indicate that MC [medical cannabis] results in long-term reduction of migraine frequency in [more than] 60% of treated patients and is associated with less disability and lower antimigraine medication intake," write the study's authors. 

As migraines are classified as a pain condition, the researchers noted that cannabis may have been effective against them as it works via the endocannabinoid system. This comes as endocannabinoids have been shown to inhibit serotonin receptors and thus modulate pain and emetic (the need to vomit) responses in living organisms. 

These findings are not the first to suggest that cannabis is able to relieve migraines. They build upon earlier evidence from a research team at the University of Colorado that found a similar link between migraines and cannabis in 2016. 

Although promising results, the researchers nevertheless warn that before a link can be proven, and therapeutics for migraines involving cannabis developed, further research is needed to demonstrate the substance's efficacy against them. 

 

Sources: High Times, MDPI, The Growth Op

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 13, 2020
Cannabis Sciences
CBD Kills Brain Cancer Cells in Petri Dish
JUN 13, 2020
CBD Kills Brain Cancer Cells in Petri Dish
Cannabis products are not only popular for their psychoactive effects. An increasing number of companies and researchers ...
JUL 01, 2020
Health & Medicine
Could THC Help Advanced Alzheimer's Symptoms?
JUL 01, 2020
Could THC Help Advanced Alzheimer's Symptoms?
More than 5 million Americans are living with Alzheimer's disease (AD) according to the Alzheimer's Organization. When t ...
AUG 11, 2020
Cannabis Sciences
High THC Cannabis Linked to Anxiety
AUG 11, 2020
High THC Cannabis Linked to Anxiety
Researchers have found that people who use strains of cannabis high in tetrahydrocannabinol (THC), the psychoactive comp ...
AUG 20, 2020
Health & Medicine
Does Recreational Marijuana Out-of-Hours Affect Work Performance?
AUG 20, 2020
Does Recreational Marijuana Out-of-Hours Affect Work Performance?
Imagine that after a busy day at work you kick back with a relaxing cannabis joint. In many states that is now entirely ...
SEP 01, 2020
Plants & Animals
Warsaw Zoo Testing CBD to Manage Elephants' Stress
SEP 01, 2020
Warsaw Zoo Testing CBD to Manage Elephants' Stress
Humans use cannabidiol (CBD) for its array of health benefits, and household pets even benefit from CBD treatments in sp ...
OCT 20, 2020
Cannabis Sciences
Should Cannabis Doses Be Standardized?
OCT 20, 2020
Should Cannabis Doses Be Standardized?
Should cannabis and its compounds such as tetrahydrocannabinol (THC), the psychoactive compound in cannabis, come in sta ...
Loading Comments...